Readers voted Redwood girls basketball player Jelena Singkeoviley as the Visalia Times-Delta Tulare County high school athlete of the week. In an online poll that closed on Jan. 24, Singkeoviley ...

ExxonMobil has made a potential play opening discovery in Egypt's frontier Herodotus basin on a prospect that, before drilling began, was estimated could hold up to 5 trillion cubic feet of gas.

Chevron’s initial bid for glory in Namibia’s Orange basin has failed, with the US operator failing to find commercial hydrocarbons with its debut exploration well. Over the past three days ...

Production from Civitas’ D-J Basin assets averaged around 160,000 boe/d (70,674 bbl/d oil) during the third quarter of 2024. Civitas Resources-operated D-J acreage and horizontal wells first online ...

You’ll learn how the lake came to be over 10,000 years ago (once the largest freshwater lake west of the Mississippi River), the flood that brought it back to life in 2023, and opportunities we now ...

Imperial Oil and Gas has reported an incident in which contaminated water was "inadvertently released" onto vegetation near a fracking well in the Beetaloo Basin. Environmental experts and ...

The oil and gas industry has been talking up the potential of the Powder River Basin for 20 years. Even so, Wyoming’s busiest play still only has about 11 rigs running. It’s going to take more than an ...

Eli Lilly has agreed to acquire Scorpion Therapeutics’ breast cancer treatment program for up to $2.5 billion in cash. The drugmaker said Monday it is acquiring Scorpion and its STX-478 program ...

Eli Lilly is reenergizing its attempt to challenge Novartis and Roche for a breast cancer market, kicking off the J.P. Morgan Healthcare Conference with a deal to buy Scorpion Therapeutics ...

We look forward to leveraging the great work of the Scorpion team to date, along with Lilly's deep expertise in breast cancer, to further advance STX-478 with speed and focus." Under the terms of ...

SAN FRANCISCO — Eli Lilly said Monday it would acquire a cancer program from startup Scorpion Therapeutics in a deal worth up to $2.5 billion, as the Indianapolis company broadens its pipeline.

Jan 13 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Monday it plans to buy Scorpion Therapeutics' experimental cancer therapy for up to $2.5 billion in cash to expand its pipeline of ...